Balance Therapeutics

About Balance Therapeutics

Balance Therapeutics, Inc. is a biotechnology company focused on developing pharmacological treatments to enhance the quality of life for individuals with neurological disorders. The company operates in the healthcare and life sciences market, targeting patients who suffer from conditions that affect the brain and nervous system. Balance Therapeutics employs a business model centered around research and development (R&D), clinical trials, and partnerships with key stakeholders in the healthcare industry. The company generates revenue through the development and commercialization of its pharmacological products, supported by significant investments from venture capital firms such as Mohr Davidow Ventures, Oakmont Corporation, Orbimed Advisors, Rock Springs Capital, and Pappas Ventures. Additionally, Balance Therapeutics has received substantial R&D support from the U.S. National Institutes of Health. The company collaborates with a team of consultants and partners across various functions including manufacturing, preclinical toxicology, clinical development, clinical operations, data management, statistics, quality, and regulatory affairs. This collaborative approach ensures the efficient progression of their drug candidates from the research phase through to clinical trials and eventual market release.